Skip to content
Search

Latest Stories

'East England ranks 5th in nation for quitting smoking', new study shows

'East England ranks 5th in nation for quitting smoking', new study shows

Study suggests vaping as "a less harmful alternative" to smoking cigarettes 

A recent study conducted by online vape store GoSmokeFree using data from the NHS Stop Smoking Service in England between April to September 2023 has revealed the regions across the UK with the highest success rates in quitting smoking.


According to the data analysis, the East of England emerges as the fifth most successful region in the UK for smoking cessation while the Isle of Wight in the South East region with 3,124 people quitting per 100,000 smokers were the most successful at quitting smoking.

The study ranked regions based on the average number of successful quitters per 100,000 smokers. The South East takes the lead, followed by the North East and the North West. The East of England secured the fifth spot with an average of 981 smokers per 100,000 successfully quitting smoking during the designated period.

Southend-on-Sea emerges as the most successful area within the East of England, boasting 1,591 smokers per 100,000 who have managed to kick the habit.

However, the data also reveals that out of 3,032 smokers who set a quit date in this region, 834 were unable to quit within the specified timeframe.

The study further breaks down the success rates by local authority areas within each region. For instance, in Lincolnshire, the most successful area within the East Midlands, 1,274 smokers per 100,000 have successfully quit out of 2,123 who set a quit date. Similarly, Gateshead in the North East and Sefton in the North West show notable success rates.

Notably, while the South West ranked the lowest amongst the regions to successfully stop smoking with only an average of 599 smokers per 100,000 giving up smoking, Cornwall has emerged with the most self-proclaimed quitters with 955 per 100,000 in total.

A spokesperson from GoSmokeFree commented on the findings, emphasizing the challenges associated with quitting smoking due to nicotine withdrawals and mental hurdles leading to long-term health issues including lung cancer and gum diseases.

The spokesperson highlighted various methods to assist individuals in their journey to quit smoking, including keeping a smoking diary, quitting cold turkey, and transitioning to vaping as a less harmful alternative.

The study underscores the importance of continued efforts to support smoking cessation initiatives across regions for improving overall health outcomes and reducing the burden of smoking-related illnesses.

More For You

Youth vaping : project to examine health impacts on children

Youth vaping : project to examine health impacts on children

Youth vaping: £62M research project to examine health impacts on children

The UK government has announced a £62 million research project to investigate the long-term health effects of vaping on young people, alongside wider influences on adolescent health and wellbeing.

While vaping is considered less harmful than smoking and can aid adult smokers in quitting, youth vaping has skyrocketed in recent years, with a quarter of 11 to 15-year-olds having tried it, the Department of Health and Social Care (DHSC) noted in a release.

Keep ReadingShow less
Public Policy Projects calls for better use of community pharmacy skill mix to improve medicines adherence
Non-adherence to medicines remains a critical issue, with an estimated 30 to 50 per cent of medicines for long-term conditions not taken as prescribed. (gettyimages)

Leverage pharmacy skill mix to improve medicines adherence - report suggests

The report also suggested expanding the community pharmacy contractual framework to enable community pharmacy to deliver medicines reviews

Pharmacy technicians and assistants should be enabled to talk to patients about their medications to improve medicines adherence, a new report has recommended.

The report, How medicines optimisation contributes to population health, published recently by policy institute Public Policy Projects, highlighted that non-adherence to medicines remains a critical issue, with an estimated 30 to 50 per cent of medicines for long-term conditions not taken as prescribed.

Keep ReadingShow less
Pharmacy contract consultation to review medicine margin and reimbursement, says Kinnock

Pharmacy contract consultation to review medicine margin and reimbursement, says Kinnock

Kinnock confirms that an announcement on the 2025/26 GP contract would be made before April 2025

The 2025/26 pharmacy contract consultation will include a review of the medicine margin and reimbursement arrangements, health and care minister Stephen Kinnock has confirmed.

Kinnock made this statement in response to a written question from Nick Timothy, Conservative MP for West Suffolk, who asked the secretary of state for health and social care, if he will review the reimbursement system for pharmacies and GP practices dispensing medicines.

Keep ReadingShow less
NPA urges immediate release of pharmacy funding crises review
Underfunding has forced record numbers of pharmacy closures (gettyimages)

Suppressing pharmacy funding crisis analysis would be ‘outrageous’, warns NPA

The NPA fears the report won’t be published until pharmacy funding consultations conclude, while CPE states there is no set timeline for finalising negotiations.

The National Pharmacy Association (NPA) has called on the NHS and the Department of Health to immediately publish the government-commissioned analysis of pharmacy underfunding and reveal the true scale of the crisis.

Commissioned by NHS England, the long-awaited independent review is expected to “lay bare the perilous financial state” of community pharmacies, which is a vital part of the nation’s health infrastructure.

Keep ReadingShow less
NHS expands pharmacogenomics trial to enhance personalised medicine
The NHS is poised to take a bold step towards personalised medicine (gettyimages)

Personalised medicine: NHS expands pharmacogenomics trial across England

With this study, the NHS aims to address barriers to the national implementation of pharmacogenomics, making personalised medicine to become standard practice

A national pharmacogenomics research study is making significant progress towards adopting personalised medicine within the NHS.

Following the success of Phase I, the PROGRESS project, which is assessing the feasibility of an NHS-wide diagnostic service to identify genetic changes associated with commonly prescribed drugs, is expanding across England.

Keep ReadingShow less